ERIN VOSS: Open Payments
NPI 1912543521 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 30 payments from 13 companies in 2025. Trend: 2023 $1,242 · 2024 $781 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $233 |
| CVRx, Inc. | 5 | $222 |
| Actelion Pharmaceuticals US, Inc. | 9 | $185 |
| AstraZeneca Pharmaceuticals LP | 1 | $123 |
| Alnylam Pharmaceuticals Inc. | 3 | $57 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| AtriCure, Inc. | 1 | $25 |
| Celgene Corporation | 1 | $19 |
Products named: Barostim Neo System, LOKELMA, OPSUMIT, OPSYNVI, AMVUTTRA, LifeVest, JARDIANCE, WINREVAIR.
Industry payments across FL — which companies pay providers there.
